Title:
ヒドラゾノ-マロニトリル類
Document Type and Number:
Japanese Patent JP5116940
Kind Code:
B2
Abstract:
Hydrazono-malonitrile derivatives of the formula (I) in which R1, R2, R3, R3' and R4 have the meanings given in Claim 1 act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS.
More Like This:
Inventors:
Egenweiler, Hans-Michael
Wolf, Michael
Bahia, Norbert
Schwerin, Pile
Ahling, Thomas
Wolf, Michael
Bahia, Norbert
Schwerin, Pile
Ahling, Thomas
Application Number:
JP2003541839A
Publication Date:
January 09, 2013
Filing Date:
October 10, 2002
Export Citation:
Assignee:
Merck Patent Gesellschaft mit beschraenkter Haftung
International Classes:
C07D237/04; A61K31/50; A61K31/501; A61K45/08; A61P1/04; A61P3/10; A61P9/04; A61P11/00; A61P11/06; A61P17/00; A61P17/06; A61P19/02; A61P19/10; A61P25/00; A61P27/16; A61P29/00; A61P31/18; A61P37/08; C07D403/12
Domestic Patent References:
JP2001503022A |
Foreign References:
US5684151 | ||||
WO2000059484A2 | ||||
WO2000026201A2 | ||||
WO1999065880A2 | ||||
WO2000059890A1 |
Other References:
J.Med.Chem.,1995年,Vol.38,p.4878-4879
Attorney, Agent or Firm:
Akio Miyazaki
Ishibashi Masayuki
Masaaki Ogata
Ohta Kengaku
Ishibashi Masayuki
Masaaki Ogata
Ohta Kengaku